🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Zydus Wellness Limited ZYDUSWELL NIFTY_SMALLNSE

Consumer Defensive · Packaged Foods · India
https://www.zyduswellness.com
Company Profile ↓
₹581.80
+44.90% 1Y
Mkt Cap₹18,510.59 Cr
P/E53.38
P/B3.24
Div. Yield0.20%
52W High₹598.30
52W Low₹373.50
Book Value₹183.12
EPS (TTM)₹10.90

Company Overview

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India, the Middle East, Asia, Africa, the Oceania, and internationally. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I'm lite a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and leave-on-products under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. It also exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Zydus Lifesciences Limited.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 20.7% CAGR over the past five years.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹3,940.00 Cr (+46.4% YoY); net profit ₹197.20 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +46.4%, earnings -43.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 20.7%, profit CAGR -14.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:20.67%
1 Year:46.40%

Compounded Profit Growth

5 Years:-14.03%
1 Year:-43.15%

Stock Price Performance

1 Year:+44.90%
6 Months:+31.84%
3 Months:+16.53%
1 Month:+13.97%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 93% of range
₹373.50 ₹598.30
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)60.01 · Neutral
Price Performance
1M+13.97%
3M+16.53%
6M+31.84%
1Y+44.90%
Valuation vs Sector

P/E of 53.38 is above the sector median of 23.79 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 20.7% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 53.4.
  • Earnings shrank at -14.0% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
53.38
Industry PE
23.79
Forward P/E
33.27
PEG Ratio
-
Book Value
₹183.12
Price to Book
3.24
P/S
4.76
EV/EBITDA
43.70
Dividend Yield
0.20%

Growth (CAGR)

Revenue 5Y
20.67%
Profit 5Y
-14.03%
Revenue (YoY)
46.40%
Earnings (YoY)
-43.15%

Profitability & Returns

ROCE
3.40%
ROE
3.38%
ROA
1.91%
Profit Margin
5.01%
Op Margin
9.03%
Gross Margin
59.97%
EPS (Latest Qtr)
₹5.09
EPS (TTM)
₹10.90

Balance Sheet & Liquidity

Debt/Equity
0.55
Quick Ratio
0.83
Current Ratio
1.88
Debt
₹3,202.80 Cr
Total Assets
₹10,307.80 Cr
Current Assets
₹1,366.70 Cr
Working Capital
₹638.20 Cr

Ownership

Promoter Holding
69.85%
Chg in Prom Hold
0.00%
FII / Inst Holding
20.72%
Chg in FII Hold
0.06%

Financial Snapshot

Enterprise Value
₹18,510.59 Cr
Total Revenue (TTM)
₹3,940.00 Cr
EBITDA
₹472.20 Cr
Free Cash Flow
₹124.70 Cr
Operating Cash Flow
₹226.40 Cr
Shares Outstanding
₹31.82 Cr
Gross Margin
59.97%
Payout Ratio
19.35%

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ZYDUSWELL Zydus Wellness Limited NIFTY_SMALLNSE 581.80 53.38 ₹18,510.59 Cr 0.20% 3.40% 3.38% 20.67% -14.03%
2 HINDUNILVR Hindustan Unilever Limited NIFTY50NSE 2,115.10 33.05 ₹4.97 L Cr 2.05% 22.15% 30.86% 2.31% 14.12%
3 ITC ITC Limited NIFTY50NSE 276.25 16.73 ₹3.46 L Cr 5.68% 36.47% 28.53% 3.65% 2.54%
4 NESTLEIND Nestlé India Limited NIFTY50NSE 1,431.80 86.10 ₹2.76 L Cr 0.82% 62.44% 79.99% 17.01% 23.05%
5 DMART Avenue Supermarts Limited NSE 3,911.80 85.73 ₹2.55 L Cr 0.00% 16.41% 12.14% 17.21% 7.69%
6 VBL Varun Beverages Limited NSE 469.60 52.29 ₹1.59 L Cr 0.42% 19.44% 15.51% 17.26% 26.57%
7 BRITANNIA Britannia Industries Limited NSE 5,325.50 50.63 ₹1.28 L Cr 1.69% 61.27% 49.61% 5.66% 2.95%
8 MARICO Marico Limited NIFTY_MIDNSE 847.70 62.38 ₹1.10 L Cr 0.47% 38.75% 41.85% 11.82% 10.61%
9 GODREJCP Godrej Consumer Products Limited NSE 1,060.60 58.31 ₹1.09 L Cr 1.84% 21.44% 14.71% 4.59% 3.02%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 713.00 Cr702.00 Cr440.00 Cr403.00 Cr783.00 Cr841.00 Cr-450.80 Cr910.60 Cr857.70 Cr650.00 Cr963.30 Cr1,476.10 Cr
Cost of Revenue -------235.60 Cr411.70 Cr387.80 Cr-353.10 Cr519.70 Cr
Gross Profit -------215.20 Cr498.90 Cr469.90 Cr-610.20 Cr956.40 Cr
Operating Expenses 568.00 Cr586.00 Cr423.00 Cr390.00 Cr620.00 Cr686.00 Cr-205.90 Cr321.60 Cr325.40 Cr628.00 Cr605.40 Cr746.40 Cr
Operating Income 138.00 Cr110.00 Cr11.00 Cr7.00 Cr156.00 Cr150.00 Cr-9.30 Cr177.30 Cr144.50 Cr-2.00 Cr4.80 Cr210.00 Cr
EBITDA 145.00 Cr116.00 Cr17.00 Cr13.00 Cr162.00 Cr155.00 Cr-18.60 Cr190.80 Cr158.60 Cr23.00 Cr55.20 Cr271.30 Cr
Interest Expense 5.00 Cr5.00 Cr6.00 Cr6.00 Cr6.00 Cr4.00 Cr-3.30 Cr4.20 Cr2.50 Cr16.00 Cr41.20 Cr38.70 Cr
Pretax Income 126.00 Cr93.00 Cr9.00 Cr4.00 Cr154.00 Cr152.00 Cr-10.10 Cr173.40 Cr145.30 Cr-51.00 Cr-41.50 Cr177.30 Cr
Tax Provision -18.90 Cr-16.74 Cr2.79 Cr3.68 Cr4.62 Cr4.56 Cr-3.70 Cr1.50 Cr17.40 Cr-2.04 Cr-1.60 Cr15.30 Cr
Net Income 145.00 Cr110.00 Cr6.00 Cr0150.00 Cr148.00 Cr-6.40 Cr171.90 Cr127.90 Cr-53.00 Cr-39.90 Cr162.00 Cr
Diluted EPS 4.573.470.190.014.724.64-0.205.404.02-1.66-1.255.09

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 431.00 Cr397.00 Cr431.00 Cr513.00 Cr843.00 Cr1,767.00 Cr1,867.00 Cr-2,242.60 Cr2,315.20 Cr2,691.20 Cr3,940.00 Cr
Cost of Revenue --------1,153.00 Cr1,146.10 Cr1,287.50 Cr1,577.20 Cr
Gross Profit --------1,089.60 Cr1,169.10 Cr1,403.70 Cr2,362.80 Cr
Operating Expenses 331.00 Cr305.00 Cr331.00 Cr387.00 Cr658.00 Cr1,446.00 Cr1,522.00 Cr-777.10 Cr884.80 Cr1,052.70 Cr2,007.10 Cr
Operating Income 92.00 Cr84.00 Cr92.00 Cr116.00 Cr172.00 Cr295.00 Cr319.00 Cr-312.50 Cr284.30 Cr351.00 Cr355.70 Cr
EBITDA 100.00 Cr91.00 Cr99.00 Cr125.00 Cr185.00 Cr321.00 Cr344.00 Cr-331.70 Cr307.60 Cr398.80 Cr472.20 Cr
Interest Expense 001.00 Cr2.00 Cr30.00 Cr140.00 Cr84.00 Cr-15.80 Cr23.70 Cr11.60 Cr95.00 Cr
Pretax Income 120.00 Cr117.00 Cr124.00 Cr150.00 Cr171.00 Cr121.00 Cr112.00 Cr-290.90 Cr260.10 Cr358.80 Cr230.50 Cr
Tax Provision 8.40 Cr11.70 Cr12.40 Cr13.50 Cr-0-20.57 Cr-6.72 Cr--19.50 Cr-6.80 Cr11.90 Cr33.30 Cr
Net Income 111.00 Cr105.00 Cr111.00 Cr137.00 Cr171.00 Cr142.00 Cr119.00 Cr-310.40 Cr266.90 Cr346.90 Cr197.20 Cr
Diluted EPS 5.585.285.586.855.874.923.739.719.768.3910.90-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 508.00 Cr568.00 Cr682.00 Cr829.00 Cr5,459.00 Cr5,590.00 Cr5,666.00 Cr-5,833.10 Cr6,148.40 Cr6,441.90 Cr10,307.80 Cr
Current Assets --------907.80 Cr1,214.30 Cr1,104.20 Cr1,366.70 Cr
Cash & Equivalents --------37.00 Cr80.00 Cr66.70 Cr110.60 Cr
Inventory --------457.50 Cr467.60 Cr517.50 Cr763.80 Cr
Receivables --------207.80 Cr283.30 Cr367.00 Cr383.80 Cr
Total Liabilities --------710.50 Cr790.90 Cr770.30 Cr4,481.80 Cr
Current Liabilities --------692.40 Cr769.40 Cr745.50 Cr728.50 Cr
Long Term Debt -------62.50 Cr0-03,034.90 Cr
Total Debt 0025.00 Cr25.00 Cr1,569.00 Cr1,519.00 Cr550.00 Cr-297.30 Cr328.70 Cr188.30 Cr3,202.80 Cr
Total Equity 406.00 Cr478.00 Cr557.00 Cr691.00 Cr3,387.00 Cr3,461.00 Cr4,568.00 Cr-5,122.60 Cr5,357.50 Cr5,671.60 Cr5,826.00 Cr
Shares Outstanding --------31.82 Cr31.82 Cr31.82 Cr31.82 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 69.00 Cr90.00 Cr77.00 Cr69.00 Cr149.00 Cr259.00 Cr287.00 Cr-91.70 Cr246.40 Cr380.00 Cr226.40 Cr
Investing Cash Flow 29.00 Cr-28.00 Cr-72.00 Cr-59.00 Cr-4,092.00 Cr-17.00 Cr-10.00 Cr--84.90 Cr-177.70 Cr-223.60 Cr-2,909.90 Cr
Financing Cash Flow -27.00 Cr-58.00 Cr-6.00 Cr-2.00 Cr4,052.00 Cr-260.00 Cr-216.00 Cr--138.50 Cr-25.70 Cr-186.30 Cr2,698.40 Cr
Capital Expenditure 3.00 Cr-4.00 Cr-31.00 Cr-8.00 Cr-17.00 Cr-24.00 Cr-18.00 Cr--45.00 Cr-28.50 Cr-66.30 Cr-101.70 Cr
Free Cash Flow 72.00 Cr86.00 Cr46.00 Cr61.00 Cr132.00 Cr235.00 Cr269.00 Cr-46.70 Cr217.90 Cr313.70 Cr124.70 Cr
Net Change in Cash 71.00 Cr4.00 Cr-1.00 Cr8.00 Cr109.00 Cr-18.00 Cr60.00 Cr--131.70 Cr43.00 Cr-29.90 Cr14.90 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------48.6%50.5%52.2%60.0%
Operating Margin % 21.3%21.2%21.3%22.6%20.4%16.7%17.1%-13.9%12.3%13.0%9.0%
Net Margin % 25.8%26.4%25.8%26.7%20.3%8.0%6.4%-13.8%11.5%12.9%5.0%
ROE % 27.3%22.0%19.9%19.8%5.0%4.1%2.6%-6.1%5.0%6.1%3.4%
ROCE % --------6.1%5.3%6.2%3.7%

Shareholding Pattern

Insiders
69.85%
Institutions
20.72%
Public Float
68.73%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ZYDUSWELL

Google News Mon, 13 Jul 2026

Should You Buy Zydus Wellness Limited (NSE:ZYDUSWELL) For Its Upcoming Dividend? - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxQWHUzeVB5TW5Ld3F6N1JMOExpNVBSQzlIU1hEQmhuT05ZbHpEN2dDOVB2aHU2ZXMzMy1LOFNwcnJMMHF3TmN4STBlb1JvbGdQV3FYMnN5LWlnUWthNmwwWW03NGNPQ0w0b3hYS282TnBOSGh1dzY2UlRyOHNPcDBMdC0tc1IzNDZjT1JNQ2…

Google News Mon, 18 May 2026

ZYDUSWELL: Significant revenue and profit growth achieved, with major acquisitions and a final dividend proposed - TradingView

<a href="https://news.google.com/rss/articles/CBMingJBVV95cUxQMGd1aXo2cDZjcmFLZHJ2UzhZMnFEXzVRUGZQSmM4R2dKNkJuTU5EV1I3QTl0NTFUMHg3eDVfYzN0OVk5VFJfTkRXRm1nNkN1V1lPdjZnN2ZoQkJ5enVmcjJjblJXaVVHNl9YRFBrZEpPZ2U3OVRCVjVaQi13LVFRdjU0em9faEc5dVFEem…

Google News ue, 09 Dec 2025

Zydus Wellness Share Price Today - Live NSE/BSE - ICICI Direct

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9odVFqa1pWRFZ0MDZZdkQyUklqdGt4RzBFUURxdmZ3ZjFlSS1jbFVNLTZWcS13VGY4NmlZaXBCTHdxTFpOVVZadzJvb2ZkRjMtaDBvYlBqd25Ed1UtNGM5ejlmMDI2c0VKZ0MwX0FRNERtZWs?oc=5" target="_blank">Zydus Wellne…

Google News Sat, 03 Jan 2026

Zydus Wellness Ltd. Share Price Today - Zydus Wellness Ltd. Stock Price Live NSE/BSE - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPbGxNUTJiMHFqWUpOcG9lUU5ZNTUxdFFNR3hCMTZ3dEJocDFLaExpTWZhZkE3MXRHc2tGa1JPR19wZFZWd2FHSWljd1BUTGRLMEcyVnB2NVlNOWZsWUdBUXVjUU0xVTgxbTl1UlpEQ2M2SThYQUoxWFZQNUk4QjJkMQ?oc=5" target="_…

Google News hu, 18 Sep 2025

Zydus Wellness Trades Ex-Split After 5-for-1 Stock Split - HDFC Sky

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE5iX2lTRW9uTG9SSEFqLVktU1otVjdoOHV3RkZDMU44bFI2Um50bG9FNlhuQ1pSdlZrYlkwUExhRXBMWVFBS1VOeG91VU53aGExNG1WYzd4eXNhT09JVGV2SEoyZ051TnFHbU55VFVkY2V1TFVy?oc=5" target="_blank">Zydus Welln…

Google News Mon, 15 Dec 2025

Are Zydus Wellness Limited's (NSE:ZYDUSWELL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxOcmFqRWVUS2NWa1NhYm1yYUlIX1V2My01MFVjeEtXTVNHRVE0cTRDYjc2TTBCbGFWTWZkdFduTjdmcmItaE9vbndhNFhIMTJWRmZ5UlYzM3RMd0xOTDBsbThHMi1IZ1RPcUJLcnFTUi1vM1IwZUNXVjZORG9KZjB2ejZIZzlEUEM0eTVzOT…

ZYDUSWELL — Frequently Asked Questions

What is the current share price of Zydus Wellness Limited (ZYDUSWELL)?

As of 2026-07-15 09:52 IST, Zydus Wellness Limited (ZYDUSWELL) trades at ₹581.80 on NSE. Its 52-week range is ₹373.50 to ₹598.30.

What is the market capitalisation of ZYDUSWELL?

Zydus Wellness Limited (ZYDUSWELL) has a market capitalisation of ₹18,510.59 Cr on NSE.

What is the P/E ratio of ZYDUSWELL?

ZYDUSWELL trades at a trailing price-to-earnings (P/E) ratio of 53.38. The industry average P/E is 23.79. Its price-to-book (P/B) ratio is 3.24.

Does ZYDUSWELL pay a dividend?

Zydus Wellness Limited (ZYDUSWELL) currently offers a dividend yield of 0.20%.

What is the return on equity (ROE) of ZYDUSWELL?

ZYDUSWELL has a return on equity (ROE) of 3.38%. Its return on capital employed (ROCE) is 3.40%.

Is ZYDUSWELL a good stock to buy?

This page provides a data-driven analysis of Zydus Wellness Limited (ZYDUSWELL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space